| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.10B | 75.01B | 73.58B | 70.27B | 60.10B | 58.54B |
| Gross Profit | 37.55B | 34.38B | 32.83B | 32.07B | 28.57B | 28.36B |
| EBITDA | 17.08B | 15.80B | 15.02B | 13.96B | 13.80B | 14.29B |
| Net Income | 8.94B | 9.12B | -40.79B | -1.06B | 6.85B | 6.03B |
Balance Sheet | ||||||
| Total Assets | 154.62B | 113.33B | 111.83B | 115.34B | 126.38B | 118.82B |
| Cash, Cash Equivalents and Short-Term Investments | 10.10B | 11.60B | 15.62B | 8.16B | 8.34B | 8.09B |
| Total Debt | 74.08B | 38.14B | 39.10B | 28.65B | 28.92B | 30.25B |
| Total Liabilities | 126.85B | 82.72B | 86.08B | 80.62B | 77.63B | 75.45B |
| Stockholders Equity | 25.02B | 27.77B | 23.23B | 31.90B | 45.50B | 39.31B |
Cash Flow | ||||||
| Free Cash Flow | 1.86B | 1.03B | 7.36B | 8.93B | 9.04B | 6.53B |
| Operating Cash Flow | 3.52B | 1.76B | 11.61B | 12.95B | 13.26B | 10.93B |
| Investing Cash Flow | -16.79B | -944.82M | -6.73B | -3.06B | -4.38B | -5.87B |
| Financing Cash Flow | 12.35B | -1.08B | 1.37B | -9.76B | -8.95B | -1.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $41.20B | 14.44 | 15.97% | 8.22% | -0.68% | 4.29% | |
75 Outperform | $18.25B | 17.86 | 27.63% | 3.02% | 10.69% | ― | |
75 Outperform | $136.45B | 19.09 | 8.97% | 1.83% | -2.06% | 21.03% | |
70 Outperform | $2.61B | 18.45 | 9.07% | 2.53% | 16.59% | 1.72% | |
66 Neutral | $27.53B | 25.03 | 14.29% | 2.92% | -5.57% | 119.49% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | $10.02B | -4.59 | -17.66% | 4.08% | -4.01% | -339.22% |